Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALL, Adult and Pediatric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04833582
What this trial is testing

Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma

Who this might be right for
Osteosarcoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 31
Not applicableStudy completedNCT03781973
What this trial is testing

Bridging the Gap to Adult Diabetes Care

Who this might be right for
Type1diabetes
The Hospital for Sick Children 484
Post-approval studies (Phase 4)Looking for participantsNCT06049680
What this trial is testing

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Who this might be right for
Malnutrition, ChildMalnutritionEssential Fatty Acid Deficiency (EFAD)+1 more
Fresenius Kabi 100
Early research (Phase 1)Looking for participantsNCT05298995
What this trial is testing

GD2-CAR T Cells for Pediatric Brain Tumours

Who this might be right for
Brain Tumor, PediatricMedulloblastoma, ChildhoodEmbryonal Tumor+4 more
Bambino Gesù Hospital and Research Institute 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT01920737
What this trial is testing

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 39
Post-approval studies (Phase 4)Study completedNCT04152629
What this trial is testing

Real World Evidence of the Efficacy and Safety of FOQUEST

Who this might be right for
Attention Deficit-Hyperactivity Disorder
Purdue Pharma, Canada 257
Testing effectiveness (Phase 2)Looking for participantsNCT07502287
What this trial is testing

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-Risk Neuroblastoma+1 more
Beijing Biotech 36
Not applicableApproved For MarketingNCT01377532
What this trial is testing

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

Who this might be right for
PheochromocytomaParaganglioma
University of California, San Francisco
Early research (Phase 1)Study completedNCT04088864
What this trial is testing

CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies

Who this might be right for
B Cell LymphomaAcute Lymphoblastic Leukemia, PediatricLymphoma
Kara Lynn Davis 10
Not applicableLooking for participantsNCT06691971
What this trial is testing

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

Who this might be right for
Subject Presenting WheezeAsthmaBronchial Disease+3 more
Aevice Health Pte. Ltd. 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980833
What this trial is testing

Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)

Who this might be right for
PIK3CA-related Overgrowth Spectrum (PROS)
Novartis Pharmaceuticals 41
Not applicableLooking for participantsNCT05691608
What this trial is testing

MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

Who this might be right for
Solid TumorLeukemia
Gustave Roussy, Cancer Campus, Grand Paris 1,800
Not applicableLooking for participantsNCT07614633
What this trial is testing

Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population

Who this might be right for
Eosinophilic Esophagitis (EoE)
Fondazione IRCCS Policlinico San Matteo di Pavia 200
Early research (Phase 1)Looking for participantsNCT05372640
What this trial is testing

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+5 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT00125840
What this trial is testing

Clofarabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more
Genzyme, a Sanofi Company
Not applicableLooking for participantsNCT06773546
What this trial is testing

Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System Disorders

Who this might be right for
Inborn Errors of Immunity
IRCCS Azienda Ospedaliero-Universitaria di Bologna 400
Early research (Phase 1)WithdrawnNCT02557854
What this trial is testing

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

Who this might be right for
RhabdomyosarcomaNeuroblastomaSarcoma+3 more
Theodore Laetsch
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07567469
What this trial is testing

A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

Who this might be right for
High-Grade Glioma (HGG)Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals 120
Early research (Phase 1)Study completedNCT04123288
What this trial is testing

Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 20
Not applicableLooking for participantsNCT01276470
What this trial is testing

Environmental Risk Factors for the Anti-synthetase Syndrome

Who this might be right for
MyositisDermatomyositisPolymyositis+2 more
National Institute of Environmental Health Sciences (NIEHS) 580
Next Page